Aripiprazole prescribing changes: Special Authority approval no longer required, new sole-subsidised brand

From 1 June, 2018, aripiprazole can be prescribed without Special Authority approval, making access easier for patients who require an alternative to other antipsychotics...

June 2018

What’s new in cardiovascular disease risk assessment and management for primary care clinicians

The recently released 2018 Cardiovascular Disease Risk Assessment and Management for Primary Care consensus statement provides updated recommendations for clinicians in primary care.

May 2018

A rising tide of type 2 diabetes in younger people: what can primary care do?

An increasing incidence of early onset type 2 diabetes in New Zealand is putting more people at risk of early mortality and complications such as cardiovascular disease at an age when other people in the community are at their prime.

May 2018

Avoiding the triple whammy in primary care: ACE inhibitor/ARB + diuretic + NSAID

Angiotensin converting enzyme (ACE) inhibitors, angiotensin-II receptor blockers (ARBs), diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs) all have the potential to decrease renal function.

May 2018

Managing gout in primary care

Part 1 - Talking about gout: time for a re-think

Gout is a treatable form of arthritis that is associated with poor health and reduced life expectancy.

April 2018

Managing gout in primary care

Part 2 - Controlling gout with long-term urate-lowering treatment

Urate-lowering medicines should be considered and discussed with patients with gout from the first presentation.

April 2018